{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:20:43Z","timestamp":1765887643499},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T00:00:00Z","timestamp":1402358400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2334-14-316","type":"journal-article","created":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T07:02:46Z","timestamp":1402383766000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A non-synonymous polymorphism in IL-23R Gene (rs1884444) is associated with reduced risk to schistosomiasis-associated Immune Reconstitution Inflammatory Syndrome in a Kenyan population"],"prefix":"10.1186","volume":"14","author":[{"given":"George O","family":"Ogola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Collins","family":"Ouma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter GZO","family":"Jura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erick O","family":"Muok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Colebunders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline N","family":"Mwinzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,10]]},"reference":[{"key":"3612_CR1","unstructured":"World AIDS day. East Mediterr Health J. 2011, 17 (12): 901"},{"issue":"5","key":"3612_CR2","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/QAD.0b013e3282f4a607","volume":"22","author":"DM Murdoch","year":"2008","unstructured":"Murdoch DM, Venter WD, Feldman C, Van Rie A: Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS. 2008, 22 (5): 601-610. 10.1097\/QAD.0b013e3282f4a607.","journal-title":"AIDS"},{"issue":"5","key":"3612_CR3","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1097\/00126334-200412150-00007","volume":"37","author":"N Kumarasamy","year":"2004","unstructured":"Kumarasamy N, Chaguturu S, Mayer KH, Solomon S, Yepthomi HT, Balakrishnan P, Flanigan TP: Incidence of immune reconstitution syndrome in HIV\/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India. J Acquir Immune Defic Syndr. 2004, 37 (5): 1574-1576. 10.1097\/00126334-200412150-00007.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"3612_CR4","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1097\/QAD.0b013e32832afefc","volume":"23","author":"K Smith","year":"2009","unstructured":"Smith K, Kuhn L, Coovadia A, Meyers T, Hu CC, Reitz C, Barry G, Strehlau R, Sherman G, Abrams EJ: Immune reconstitution inflammatory syndrome among HIV-infected South African infants initiating antiretroviral therapy. AIDS. 2009, 23 (9): 1097-1107. 10.1097\/QAD.0b013e32832afefc.","journal-title":"AIDS"},{"issue":"4","key":"3612_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/01.aids.0000161769.06158.8a","volume":"19","author":"SA Shelburne","year":"2005","unstructured":"Shelburne SA, Visnegarwala F, Darcourt J, Graviss EA, Giordano TP, White AC, Hamill RJ: Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS. 2005, 19 (4): 399-406. 10.1097\/01.aids.0000161769.06158.8a.","journal-title":"AIDS"},{"issue":"2","key":"3612_CR6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1468-1293.2005.00277.x","volume":"6","author":"DJ Jevtovic","year":"2005","unstructured":"Jevtovic DJ, Salemovic D, Ranin J, Pesic I, Zerjav S, Djurkovic-Djakovic O: The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy. HIV Med. 2005, 6 (2): 140-143. 10.1111\/j.1468-1293.2005.00277.x.","journal-title":"HIV Med"},{"issue":"6","key":"3612_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S1473-3099(05)70140-7","volume":"5","author":"SD Lawn","year":"2005","unstructured":"Lawn SD, Bekker LG, Miller RF: Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis. 2005, 5 (6): 361-373. 10.1016\/S1473-3099(05)70140-7.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"3612_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/QAD.0b013e328011efac","volume":"21","author":"SD Lawn","year":"2007","unstructured":"Lawn SD, Myer L, Bekker LG, Wood R: Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS. 2007, 21 (3): 335-341. 10.1097\/QAD.0b013e328011efac.","journal-title":"AIDS"},{"issue":"2","key":"3612_CR9","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/jac\/dki444","volume":"57","author":"SA Shelburne","year":"2006","unstructured":"Shelburne SA, Montes M, Hamill RJ: Immune reconstitution inflammatory syndrome: more answers, more questions. J Antimicrob Chemother. 2006, 57 (2): 167-170. 10.1093\/jac\/dki444.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"3612_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/01.inf.0000195618.55453.9a","volume":"25","author":"T Puthanakit","year":"2006","unstructured":"Puthanakit T, Oberdorfer P, Akarathum N, Wannarit P, Sirisanthana T, Sirisanthana V: Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected thai children. Pediatr Infect Dis J. 2006, 25 (1): 53-58. 10.1097\/01.inf.0000195618.55453.9a.","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"3612_CR11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.autrev.2003.09.005","volume":"3","author":"M Stoll","year":"2004","unstructured":"Stoll M, Schmidt RE: Adverse events of desirable gain in immunocompetence: the Immune Restoration Inflammatory Syndromes. Autoimmun Rev. 2004, 3 (4): 243-249. 10.1016\/j.autrev.2003.09.005.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"3612_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s11904-004-0018-7","volume":"1","author":"M Stoll","year":"2004","unstructured":"Stoll M, Schmidt RE: Immune restoration inflammatory syndromes: apparently paradoxical clinical events after the initiation of HAART. Curr HIV\/AIDS Rep. 2004, 1 (3): 122-127. 10.1007\/s11904-004-0018-7.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"2","key":"3612_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2165\/00003495-200868020-00004","volume":"68","author":"DJ Dhasmana","year":"2008","unstructured":"Dhasmana DJ, Dheda K, Ravn P, Wilkinson RJ, Meintjes G: Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy: pathogenesis, clinical manifestations and management. Drugs. 2008, 68 (2): 191-208. 10.2165\/00003495-200868020-00004.","journal-title":"Drugs"},{"issue":"11","key":"3612_CR14","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S1473-3099(10)70170-5","volume":"10","author":"LJ Haddow","year":"2010","unstructured":"Haddow LJ, Colebunders R, Meintjes G, Lawn SD, Elliott JH, Manabe YC, Bohjanen PR, Sungkanuparph S, Easterbrook PJ, French MA, Boulware DR, International Network for the Study of HIV-associated IRIS (INSHI): Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis. 2010, 10 (11): 791-802. 10.1016\/S1473-3099(10)70170-5.","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"3612_CR15","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S1473-3099(10)70280-2","volume":"10","author":"SD Lawn","year":"2010","unstructured":"Lawn SD, Wood R: Immune reconstitution inflammatory syndrome. Lancet Infect Dis. 2010, 10 (12): 833-834. 10.1016\/S1473-3099(10)70280-2.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"3612_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S1386-6532(01)00200-1","volume":"22","author":"P Price","year":"2001","unstructured":"Price P, Mathiot N, Krueger R, Stone S, Keane NM, French MA: Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy. J Clin Virol. 2001, 22 (3): 279-287. 10.1016\/S1386-6532(01)00200-1.","journal-title":"J Clin Virol"},{"issue":"15","key":"3612_CR17","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1097\/00002030-200210180-00009","volume":"16","author":"P Price","year":"2002","unstructured":"Price P, Morahan G, Huang D, Stone E, Cheong KY, Castley A, Rodgers M, McIntyre MQ, Abraham LJ, French MA: Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases. AIDS. 2002, 16 (15): 2043-2047. 10.1097\/00002030-200210180-00009.","journal-title":"AIDS"},{"issue":"11","key":"3612_CR18","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.4049\/jimmunol.168.11.5699","volume":"168","author":"C Parham","year":"2002","unstructured":"Parham C, Chirica M, Timans J, Vaisberg E, Travis M, Cheung J, Pflanz S, Zhang R, Singh KP, Vega F, To W, Wagner J, O'Farrell AM, McClanahan T, Zurawski S, Hannum C, Gorman D, Rennick DM, Kastelein RA, de Waal Malefyt R, Moore KW: A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol. 2002, 168 (11): 5699-5708. 10.4049\/jimmunol.168.11.5699.","journal-title":"J Immunol"},{"issue":"1","key":"3612_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1189\/jlb.0602326","volume":"73","author":"CS Lankford","year":"2003","unstructured":"Lankford CS, Frucht DM: A unique role for IL-23 in promoting cellular immunity. J Leukoc Biol. 2003, 73 (1): 49-56. 10.1189\/jlb.0602326.","journal-title":"J Leukoc Biol"},{"key":"3612_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1600-065X.2008.00699.x","volume":"226","author":"Y Iwakura","year":"2008","unstructured":"Iwakura Y, Nakae S, Saijo S, Ishigame H: The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol Rev. 2008, 226: 57-79. 10.1111\/j.1600-065X.2008.00699.x.","journal-title":"Immunol Rev"},{"issue":"2","key":"3612_CR21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/ar2392","volume":"10","author":"S Romagnani","year":"2008","unstructured":"Romagnani S: Human Th17 cells. Arthritis Res Ther. 2008, 10 (2): 206-10.1186\/ar2392.","journal-title":"Arthritis Res Ther"},{"key":"3612_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.0105-2896.2004.00214.x","volume":"202","author":"CL Langrish","year":"2004","unstructured":"Langrish CL, McKenzie BS, Wilson NJ, de Waal Malefyt R, Kastelein RA, Cua DJ: IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev. 2004, 202: 96-105. 10.1111\/j.0105-2896.2004.00214.x.","journal-title":"Immunol Rev"},{"issue":"7","key":"3612_CR23","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/ng2061","volume":"39","author":"M Parkes","year":"2007","unstructured":"Parkes M, Barrett JC, Prescott NJ, Tremelling M, Anderson CA, Fisher SA, Roberts RG, Nimmo ER, Cummings FR, Soars D, Drummond H, Lees CW, Khawaja SA, Bagnall R, Burke DA, Todhunter CE, Ahmad T, Onnie CM, McArdle W, Strachan D, Bethel G, Bryan C, Lewis CM, Deloukas P, Forbes A, Sanderson J, Jewell DP, Satsangi J, Mansfield JC, Cardon L, Mathew CG, Wellcome Trust Case Control Consortium, et al: Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet. 2007, 39 (7): 830-832. 10.1038\/ng2061.","journal-title":"Nat Genet"},{"issue":"2","key":"3612_CR24","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1086\/511051","volume":"80","author":"M Cargill","year":"2007","unstructured":"Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP, Matsunami N, Ardlie KG, Civello D, Catanese JJ, Leong DU, Panko JM, McAllister LB, Hansen CB, Papenfuss J, Prescott SM, White TJ, Leppert MF, Krueger GG, Begovich AB: A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet. 2007, 80 (2): 273-290. 10.1086\/511051.","journal-title":"Am J Hum Genet"},{"issue":"8","key":"3612_CR25","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1136\/gut.2007.122069","volume":"56","author":"J Van Limbergen","year":"2007","unstructured":"Van Limbergen J, Russell RK, Nimmo ER, Drummond HE, Smith L, Davies G, Anderson NH, Gillett PM, McGrogan P, Hassan K, Weaver L, Bisset WM, Mahdi G, Wilson DC, Satsangi J: IL23R Arg381Gln is associated with childhood onset inflammatory bowel disease in Scotland. Gut. 2007, 56 (8): 1173-1174. 10.1136\/gut.2007.122069.","journal-title":"Gut"},{"issue":"5804","key":"3612_CR26","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1126\/science.1135245","volume":"314","author":"RH Duerr","year":"2006","unstructured":"Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW, Kistner EO, Schumm LP, Lee AT, Gregersen PK, Barmada MM, Rotter JI, Nicolae DL, Cho JH: A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006, 314 (5804): 1461-1463. 10.1126\/science.1135245.","journal-title":"Science"},{"issue":"2","key":"3612_CR27","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/jid.2008.233","volume":"129","author":"U Huffmeier","year":"2009","unstructured":"Huffmeier U, Lascorz J, Bohm B, Lohmann J, Wendler J, Mossner R, Reich K, Traupe H, Kurrat W, Burkhardt H, Reis A: Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis. J Invest Dermatol. 2009, 129 (2): 355-358. 10.1038\/jid.2008.233.","journal-title":"J Invest Dermatol"},{"issue":"8","key":"3612_CR28","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1086\/592055","volume":"198","author":"C Ouma","year":"2008","unstructured":"Ouma C, Davenport GC, Awandare GA, Keller CC, Were T, Otieno MF, Vulule JM, Martinson J, Ong'echa JM, Ferrell RE, Perkins DJ: Polymorphic variability in the interleukin (IL)-1beta promoter conditions susceptibility to severe malarial anemia and functional changes in IL-1beta production. J Infect Dis. 2008, 198 (8): 1219-1226. 10.1086\/592055.","journal-title":"J Infect Dis"},{"issue":"1","key":"3612_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1128\/IAI.00895-09","volume":"78","author":"C Ouma","year":"2010","unstructured":"Ouma C, Keller CC, Davenport GC, Were T, Konah S, Otieno MF, Hittner JB, Vulule JM, Martinson J, Ong'echa JM, Ferrell RE, Perkins DJ: A novel functional variant in the stem cell growth factor promoter protects against severe malarial anemia. Infect Immun. 2010, 78 (1): 453-460. 10.1128\/IAI.00895-09.","journal-title":"Infect Immun"},{"issue":"10","key":"3612_CR30","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nri1706","volume":"5","author":"AT Haase","year":"2005","unstructured":"Haase AT: Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol. 2005, 5 (10): 783-792. 10.1038\/nri1706.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"3612_CR31","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/viro.1994.1526","volume":"204","author":"S Jurriaans","year":"1994","unstructured":"Jurriaans S, Van Gemen B, Weverling GJ, Van Strijp D, Nara P, Coutinho R, Koot M, Schuitemaker H, Goudsmit J: The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course?. Virology. 1994, 204 (1): 223-233. 10.1006\/viro.1994.1526.","journal-title":"Virology"},{"issue":"5","key":"3612_CR32","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1371\/journal.pmed.0040177","volume":"4","author":"A Yates","year":"2007","unstructured":"Yates A, Stark J, Klein N, Antia R, Callard R: Understanding the slow depletion of memory CD4+ T cells in HIV infection. PLoS Med. 2007, 4 (5): e177-10.1371\/journal.pmed.0040177.","journal-title":"PLoS Med"},{"issue":"2","key":"3612_CR33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4269\/ajtmh.1998.59.307","volume":"59","author":"DM Karanja","year":"1998","unstructured":"Karanja DM, Boyer AE, Strand M, Colley DG, Nahlen BL, Ouma JH, Secor WE: Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1. Am J Trop Med Hyg. 1998, 59 (2): 307-311.","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"3612_CR34","doi-asserted-by":"crossref","first-page":"515","DOI":"10.4269\/ajtmh.1997.56.515","volume":"56","author":"DM Karanja","year":"1997","unstructured":"Karanja DM, Colley DG, Nahlen BL, Ouma JH, Secor WE: Studies on schistosomiasis in western Kenya: I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections. Am J Trop Med Hyg. 1997, 56 (5): 515-521.","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"3612_CR35","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1086\/322783","volume":"184","author":"PN Mwinzi","year":"2001","unstructured":"Mwinzi PN, Karanja DM, Colley DG, Orago AS, Secor WE: Cellular immune responses of schistosomiasis patients are altered by human immunodeficiency virus type 1 coinfection. J Infect Dis. 2001, 184 (4): 488-496. 10.1086\/322783.","journal-title":"J Infect Dis"},{"issue":"4","key":"3612_CR36","doi-asserted-by":"crossref","first-page":"676","DOI":"10.4269\/ajtmh.2007.77.676","volume":"77","author":"K Watanabe","year":"2007","unstructured":"Watanabe K, Mwinzi PN, Black CL, Muok EM, Karanja DM, Secor WE, Colley DG: T regulatory cell levels decrease in people infected with Schistosoma mansoni on effective treatment. Am J Trop Med Hyg. 2007, 77 (4): 676-682.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"3612_CR37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4269\/ajtmh.1980.29.217","volume":"29","author":"PA Peters","year":"1980","unstructured":"Peters PA, El Alamy M, Warren KS, Mahmoud AA: Quick Kato smear for field quantification of Schistosoma mansoni eggs. Am J Trop Med Hyg. 1980, 29 (2): 217-219.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"3612_CR38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1086\/499109","volume":"42","author":"S de Silva","year":"2006","unstructured":"de Silva S, Walsh J, Brown M: Symptomatic Schistosoma mansoni infection as an immune restoration phenomenon in a patient receiving antiretroviral therapy. Clin Infect Dis. 2006, 42 (2): 303-304. 10.1086\/499109.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"3612_CR39","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0531-5565(03)00189-X","volume":"38","author":"P Pietschmann","year":"2003","unstructured":"Pietschmann P, Gollob E, Brosch S, Hahn P, Kudlacek S, Willheim M, Woloszczuk W, Peterlik M, Tragl KH: The effect of age and gender on cytokine production by human peripheral blood mononuclear cells and markers of bone metabolism. Exp Gerontol. 2003, 38 (10): 1119-1127. 10.1016\/S0531-5565(03)00189-X.","journal-title":"Exp Gerontol"},{"issue":"7","key":"3612_CR40","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/gene.2008.64","volume":"9","author":"SH Kan","year":"2008","unstructured":"Kan SH, Mancini G, Gallagher G: Identification and characterization of multiple splice forms of the human interleukin-23 receptor alpha chain in mitogen-activated leukocytes. Genes Immun. 2008, 9 (7): 631-639. 10.1038\/gene.2008.64.","journal-title":"Genes Immun"},{"issue":"4","key":"3612_CR41","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.4049\/jimmunol.180.4.2486","volume":"180","author":"LI Rutitzky","year":"2008","unstructured":"Rutitzky LI, Bazzone L, Shainheit MG, Joyce-Shaikh B, Cua DJ, Stadecker MJ: IL-23 is required for the development of severe egg-induced immunopathology in schistosomiasis and for lesional expression of IL-17. J Immunol. 2008, 180 (4): 2486-2495. 10.4049\/jimmunol.180.4.2486.","journal-title":"J Immunol"},{"issue":"Suppl 1","key":"3612_CR42","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1590\/S0074-02762006000900052","volume":"101","author":"LI Rutitzky","year":"2006","unstructured":"Rutitzky LI, Stadecker MJ: CD4 T cells producing pro-inflammatory interleukin-17 mediate high pathology in schistosomiasis. Mem Inst Oswaldo Cruz. 2006, 101 (Suppl 1): 327-330.","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"5","key":"3612_CR43","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.4049\/jimmunol.0901504","volume":"183","author":"PM Smith","year":"2009","unstructured":"Smith PM, Shainheit MG, Bazzone LE, Rutitzky LI, Poltorak A, Stadecker MJ: Genetic control of severe egg-induced immunopathology and IL-17 production in murine schistosomiasis. J Immunol. 2009, 183 (5): 3317-3323. 10.4049\/jimmunol.0901504.","journal-title":"J Immunol"},{"issue":"11","key":"3612_CR44","doi-asserted-by":"publisher","first-page":"e40623","DOI":"10.1371\/journal.pone.0040623","volume":"7","author":"LJ Haddow","year":"2012","unstructured":"Haddow LJ, Moosa MY, Mosam A, Moodley P, Parboosing R, Easterbrook PJ: Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa. PLoS One. 2012, 7 (11): e40623-10.1371\/journal.pone.0040623.","journal-title":"PLoS One"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-316.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-14-316\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-316","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-316.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T04:06:14Z","timestamp":1630555574000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-14-316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,10]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3612"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-14-316","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,10]]},"assertion":[{"value":"21 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"316"}}